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Summary
We have characterized four IgG monoclonal antibodies (mAbs) derived fromBALB/c mice that
bind double-stranded DNA (dsDNA) with high affinity. The hydridomas were selected for
expression of a member of the VHS107 family . Three of the four cell lines use the VH11 gene
and one uses the VH1 gene . These antibodies exhibit many characteristics of pathogenic anti-
DNA antibodies. They are high affinity and not broadly crossreactive . Unlike the anti-DNA
antibodies in autoimmune mice, they exhibit no somatic mutation in their VH genes. These
results demonstrate that somatic mutation ofVHS107 genes is not necessary for generating high
affinitydsDNA binding. The fact that such antibodies have not previously been reported suggests
that they are rare and that their expression may be downregulated in both nonautoimmune and
autoimmune individuals.
R
ecent analyses ofautoantibodies have established that there
are two qualitatively different classes ofautoantibodies .
One class is the "natural" autoantibodies, made by auto-
antibody-producing B cell lines derived from both normal
individuals and individuals with autoimmune disease; the other
class can be derived only from autoimmune individuals. The
physiologic function of the ubiquitous "natural" autoanti-
bodies is not known and it is assumed that they have no patho-
genic potential (1-5) . "Natural" autoantibodies have been in-
duced in normal and autoimmune strains both in vitro and
in vivo by stimulation with bacterial LPS, a polyclonal B cell
activator (6-9) . Monoclonal autoantibodies derived from LPS-
stimulated B cells are generally ofthe IgM isotype, are widely
crossreactive with a variety of autoantigens and exogenous
antigens, and are encoded by unmutated germline genes. Most
of these antibodies are low affinity, but some may exhibit
moderate binding to a particular autoantigen (10) . However,
because they are pentameric IgM, it is difficult to attribute
this binding to true affinity. It has been suggested that these
autoantibodies are the product of a particular B cell lineage
that displays theCD5 (Ly1) markeron themembrane (11, 12) .
In contrast, (NZB x NZW)Fi and MRL/1pr autoim-
mune strains spontaneously produce various autoantibodies
that differ in anumber of parameters from natural autoanti-
bodies. Autoimmune animals produce high affinity autoan-
tibodies of the IgG isotype that are not widely crossreactive
and are encoded by somatically mutated genes (13-16) . Au-
toantibodies with these characteristics are a hallmark ofboth
the human disease SLE and of the (NZB x NZW)Fi and
MRL/lpr mouse models of the human disease. Furthermore,
these autoantibodies are believed to have pathogenic poten-
tial, since autoantibodies eluted from diseased kidneys of au-
toimmune mice exhibit the same characteristics : they are IgG,
high affinity, and not broadly crossreactive (1, 17-21) . Au-
toantibodies with these characteristics have not previously
been found in nonautoimmune strains. Some investigators
have speculated that these disease-associated autoantibodies
may be the somatically mutated progeny of natural autoanti-
bodies (22) .
In this paper we describe fouranti-DNA antibodies secreted
by hybridomas derived fromBALB/c mice. Three of the four
hybridoma antibodies reported here were derived from animals
immunized with an anti-I-J antibody (23), and a fourth was
produced in an animal that received a single immunization
of phosphorylcholine (PC)' coupled to a protein carrier.
These anti-dsDNA hybridomas were selected for expression
of a member of the S107 VH family. The S107 gene family
has four members, (VH1, VH3, VH11, and VH13) and is
known to be important in the protective immune responses
to pneumococcal bacteria (VH1) and to influenza (VH11) in
BALB/c mice. Previous studies showed that a single amino
acid substitution in the PC-binding, VH1-encoded myeloma
cell line S107, resulted in production of the U4 antibody,
which no longer boundPC but had acquired reactivity with
dsDNA (24) . The analysis of the U4 mutant suggested that
the S107 gene family might contribute to the in vivo produc-
1 Abbreviations used in this paper.ARS, p-azo-phenylarsonate ; HGG, human
gammaglobulin ; PC, phosphorylcholine .
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bridoma antibodies have shown that the S107 family is in-
deed used in the anti-DNA response in both the (NZB x
NZW)Fi and MRL/lpr strains of mice (13-15, 25). The an-
tibodies reported here have features of autoantibodies found
in autoimmune disease; they are IgG, have high affinity for
dsDNA and are not broadly crossreactive. They differ from
theautoantibodies foundin autoimmune diseasebecausethey
are encoded by germline VH genes containing no somatic
mutations. Two are encodedby germline Vk genes also; the
germline Vk genes for the other two antibodies are not
known so it is not possible to determine whether the ex-
pressed Vk genes are unmutated, although this is likely to
be the case. Autoantibodies with these characteristics in au-
toimmune disease display extensive somatic diversification.
The detailed analysis of these four antibodies leads us to
posit a new thirdclassautoantibody, aclass ofhighly specific
IgG anti-DNA antibodies that are encoded by nonmutated
germline genes and that may not generally be expressed ei-
ther in normals or in individuals with lupus-like autoimmune
disease. The existence of these antibodies raises new ques-
tions about the nature of germline gene-encoded antibodies
and the regulatory defect that maybe present in autoimmunity.
Materials and Methods
Cell Lines.
￿
8-wk-old female BALB/c mice were immunizedin-
traperitoneally with either anti-IJd 50 ug in CFA or PC con-
jugatedto human gammaglobulin (HGG), 100hg in CFA. Mice
were boostedintravenouslywith either 10014g PC coupled to KLH,
100Ftgp-azo-phenylarsonate (ARS)-KLH, or 100wl of an antiserum
to the T15 idiotype (Table 1). The antiidiotype was prepared as
follows: rabbits were immunized with 5107 protein and high ti-
tered antiserumwas then absorbed on an irrelevant mouse IgAan-
tibody (W1329)-Sepharose to render it variable region specific.
Spleen cells from the immunized mice were fused to the non-
producingHATsensitivemyelomacell line X63Ag8.653 (26). Hy-
bridomas were plated in 96-well tissue culture plates in HAT
containing medium and screened 2 wk laterby RNAdot blot for
expression of a T15 Vii gene.
RNA Dot BlotAnalysis.
￿
Cells were lysedin 96-well plates and
filtered throughnitrocellulose with a 96-well manifold (Schleicher
&Schnell, Keene, NH) andhybridized to a210-bp nick-translated
probe that detectsall members of the S107 VH gene family (27, 28).
Table 1 .
￿
Anti-dsDNA mAbs from BALB/c Mice
Cell line
￿
Immunization protocol
21311.1
￿
aIJd, 5 wk
Ars-KLH, 4 d
C8 .5
￿
al4d, 7 wk
ctT15, 4 d
7D2.G12
￿
aIJd, 4 wk
PC-KLH, 3 d
R4A.12
￿
PC-HGG, 1 wk
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mRNA Preparation andSequencing.
￿
TotalRNAwasisolated from
hybridoma cells by extraction with guanidinium thiocyanate.
Sampleswere dissolvedin 10 mM Tris-Cl, 1 mM EDTA, 400mM
NaCl heated to 68°C and loaded three times onto oligo(dT)-
cellulose columns (Collaborative Research Inc., Bedford, MA).
mRNA was eluted with TE (10 mM Tris-Cl, 1 mM EDTA) and
precipitated with ethanol. Theprecipitate was dissolved in mRNA
annealing buffer (250 mM KCI, 10 mM Tris-Cl, 1 mM EDTA)
for sequencing. mRNA was annealed to radiolabeled Ig constant
region oligonucleotide primers and dideoxy sequencing was per-
formed according to Geliebter et al. (29).
Normalization ofCell SupernatantsforIg Concentration.
￿
Cellswere
grownin serum-free medium containing 5.0 Ag/mlbovine insulin,
3.5 wg/ml human transferrin, 0.1% sodium selenite, and 0.1%
ethanolamine, in a 1:1 mixtureofDME (1,000 mg glucose perliter)
and Ham's F12nutrient mixture(Hazelton, St. Lenexa, KS). The
Ig contentof each culture supernatant was determined by ELISA.
96-well polystyrene E.I.A. plates (CostarCorp., Cambridge, MA)
werecoated for2hat 37°Cwithan anti-IgGisotypic reagent (Fisher
Biotech, Orangeburg, NY) appropriate for each cell line. Plates
were blocked with 1% BSAin PBS overnight at 4°C, andcell su-
pernatants or dilutions ofcommercially purified Igs (Litton Bio-
netics, Charleston, SC) were addedand the plates were incubated
for 90 min at 37°C. Plates were washed three times with PBS,
0.05% Tween, and then incubatedwith alkaline phosphatase-con-
jugatedanti-mouse IgGisotypic reagentfor90min at 37°C. Plates
were washed again and developed with alkaline phosphatase sub-
strate (Sigma Chemical Co., St. Louis, MO). Plates were read in
a Titertek ELISA reader (Flow Laboratories, McLean, VA) at
405 nm.
Millipore FilterAssay.
￿
Nick-translatedDNAwas made double-
stranded by passage through a 0.45-pm nitrocellulose Millex sy-
ringe filter (Millipore Products Division, Bedford, MA). Cell su-
pernatants normalized for Ig concentration were incubated with
10,000 cpm of "P-labeled, dsDNA in 96-well nitrocellulose-
bottom Millititer-HA plates (Millipore Products Division) for90
min at 37°C. The dsDNA/cell supernatant mixtures were then
filtered through the nitrocellulose and washed three times with
1x SSC (0.15MNaCl, 0.015 Mcitrate, pH 7.2) on a96-well vacuum
filtration apparatus(Millipore Products Division). Thewells were
punched out and counted on an LKB-RackBeta (Pharmacia LKB
Biotechnology, Inc., Piscataway, NJ) scintillation counter.
DNA ELISA.
￿
Round-bottomed, polyvinylplates (Falcon Lab-
ware, Oxnard, CA) were coated with 100 pl per well of poly-L-
lysine (50wg/ml),andincubatedfor2h at 37°C. Plates were shaken
dry and rinsed with distilled water. 100 pl of calf thymus (CT)
DNA either filtered (as above for dsDNA) or boiled for 10 min
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Isotype VN D JH VK JK
IgG2b 1 DFL16.2 3 8 1
IgG1 11 DFL16.1 1 Vt20 5
IgG3 11 DFL16.1 1 12, 13 1
IgG3 11 ? 4 1 1and quickly cooled on ice (dDNA) was added at 4°C overnight.
The plates were blockedwith 1% BSAin PBS for90 min, washed
three timeswith PBS, 0.05% Tween 20, and then 50,ul of normal-
ized serum-free supernatant or 50 14 of serum of 1:500 dilution
in 1% BSA/PBS was applied. After a 90-min incubation and
washing, agoat anti-mouse K chainreagent or asheepanti-mouse
IgG reagent conjugated to horseradish peroxidase (Fisher Biotech,
Orangeburg, NY) was applied and incubatedfor90 minat 37°C.
Plates were then washed again, ABTS peroxidase substrate (Kir-
kegaard and Perry Laboratories, Gaithersburg, MD) was applied,
and color development was monitored at 405 urn.
Inhibition ofdsDNA Binding.
￿
100P1 per well of CT DNA (ds
or ss) at various dilutions in PBS was preincubated with 15 ul of
serum-free cell supernatant normalized to 40 wg/ml (final concen-
tration 6.3 hg/ml) at 37°C for 1 h in a 96-well, nitrocellulose-
bottomed plate. 10 pl containing 15,000 cpm of 12P-labeled dsDNA
wasadded per well and the incubation wascontinuedforan addi-
tional hour at 37°C. The mixtures were filtered through the
nitrocellulose on a 96-well vaccuum filtration apparatus and the
wells were washed and counted as above.
ELISAsfor OtherAntigenic Specicities.
￿
Bindingto thyroglob-
ulin, mycobacteria 65-kD protein, PC-BSA, p-aminophosphoryl-
choline, andL-o-glycerophosphorylcholine wasmeasured as follows.
Antigen wasdiluted to 10,ug/ml PBS and 501.l wasadded to each
well of a 96-well polystyrene EIA plate (Costar Corp.) for 2 h at
37°C. The plates were blocked with 100 Al per well of 1% BSA
in PBSat 4°C overnight. Plates were washed three timeswith BSA
0.05% Tween 20. Samples were added at concentrations ranging
between 1 and20 14g/ml (50P,1 perwell)at 37°Cfor90 min, washed
three times with PBS, 0.05% Tween20 and then incubated with
a peroxidase-linked anti-mouse K chain reagent (Fisher Biotech)
for 90 min at 37°C followed by three washes with PBS 0.05%
Tween 20 and a final rinsewith dH20. Plates were developed with
hydrogen peroxide andABTS (Kirkegaard andPerry Laboratories)
and read at 405 urn.
For analysis ofbindingto phosphatidylethanolamine, phospha-
tidylinositol, and phosphatidylserine, antigens were diluted to 10
,ug/ml in methanol and 50 ul per well of antigen was added to
polystyrene plates. Theplates were allowed to dry overnight at room
temperature, then were blocked for 2 h at 37°C with 1% BSA
in PBS. The remainder of the assay was performed as above.
For analysis of binding to myosin, mouse cardiac myosin was
diluted to 2.5 jig/ml in a buffer containing 36.6 mM NaHC03,
12.8 mM Na2CO3, and 50 mM tetrasodium pyrophosphate. POIy-
styrene plates were coated with 100jul ofmyosin solution perwell
for 1 h at 37°C. The buffer was then discarded and the plate was
allowed to dry overnight (30). The plate was blocked with 1%
BSA/PBS for 2 h at 37°C and the assay performed as above.
For analysis ofbindingto influenza, polystyrene plates were coated
with 50 ul of 2.5 x 105 HAU/ml of influenza virus strain PR8.
The plates was dried overnight at room temperature and given a
15-min wash with methanol followed by two PBS washes. The
plates were then blocked as usual with 1% BSA/PBS andthe assay
was performed as above.
Results
BALB/c mice were immunized using two protocols in-
tended to elicit anti-DNA antibodies encoded by members
of the S107 heavy chain variable region gene family (VH
family). One strategy of immunization wasdesigned to permit
expression of anti-dsDNA antibodies by attempting to in-
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terfere with normal suppression of autoimmunity . This pro-
tocol involves the use of an anti-I-J" antibody, WF18.2B15
(23). The I-J molecule, present on suppressor T cells, is be-
lieved to play a role in mediatingsuppressor cell activity since
antibody to IJ can block induction of suppressor activity.
Our laboratory haspreviously shown that polyclonal antiidi-
otypeto anti-IJcan abrogate suppression in an in vitro assay
system (23). In preparingmonoclonal antiidiotypic reagents
to anti-I-Jd, we observed high-titered anti-dsDNA anti-
bodies as well as antiidiotype in BALB/c (H-2d) mice im-
munized with anti-I-Jd. The anti-DNA response of several
groups of mice immunized with anti-IJd was monitored by
ELISA. Results from one group are illustrated in Fig. 1. The
repetitive cycling of the anti-DNA response over a period
of several months was reproduced in largenumbers of mice.
The high-titered anti-DNA activity in the anti-IJd im-
munizedmice led us to use this model to generate anti-dsDNA
mAbs in BALB/c mice. Subsequent analysis showed that many
of theseanimals also hadelevated S107 idiotype in theirserum.
In an effort to bias towards the production of S107 VH-
encoded anti-dsDNA antibodies, we boosted the mice with
PC-KLH or anti-5107 idiotype. As a control, we boosted
with thehapten ARS that hasalso been implicated in an anti-
DNA response but elicits antibodies encoded by a different
VH gene family (5). The second strategy for the production
of 5107-encoded anti-DNA antibodies was to immunize
BALB/c mice with PC in an attempt to isolate U4-like anti-
dsDNA mAbs that might arise by in vivo somatic mutation
of anti-PC antibodies encoded by an S107 VH gene.
Spleen cells from the immunized mice were fused to the
nonproducing myeloma cell line X63Ag8.653 by conventional
methods. The hybridomas were screened first by RNA dot
blot using a heavy chain probe that detects all members of
the S107 VH gene family. Supernatants from wells expressing
an S107 heavy chain were analyzed for isotype. We were in-
ANTI-IJd IMMUNIZED MICE
3
￿
5
￿
7
￿
9
￿
I I
￿
13
￿
15
Week After Immunization
Figure 1.
￿
Mouseserawerediluted 1:500andanalyzed by dsDNAELISA.
TheELISAwasdevelopedwith aperoxidase-conjugated anti-mouse IgG
reagent. Themean dsDNA binding plus 2 SD of a panel of eight unim-
munized age-matched BALB/c has been subtracted from the values that
are shown.Hybridoma cell supernatants were analyzed by millipore filter assay at
2 Fig/ml. The S107 parental (IgA) non-DNA binding cell line and the
U4 mutant (IgA) DNA binding cell line are described elsewhere (24) .
A
RU AGGATCC
JN4
CTATGGACTACTGGGGTCAAGGAACCTCAGTCACCGTCTCCTCAG
---------------------------------------------
terested primarily in T15 antibodies of the IgG isotype. All
T15 IgG antibodies were, therefore, analyzed for their ability
to bind dsDNA by millipore filter assay. Four IgG-secreting
hybridoma cell lines were isolated and are described in Table
1 . The anti-DNA activity ofthe antibodies secreted by these
cell lines was compared with that of the 5107 (PC-binding)
IgA antibody and theU4 (dsDNA binding) mutant IgA an-
tibody (Table 2) . Each antibody bindDNA as well as or better
than the dimeric IgAU4 antibody and equivalently to a 1:1,000
dilution of serum from an autoimmune mouse (data not
shown) .
The heavy and light chain variable regions of these four
antibodies were analyzed bymRNA dideoxy sequencing and
the results are shown in Figs. 2 and 3 . Fig. 2 a shows the
heavy chain variable region genes compared to their corre-
sponding germline genes . All of the antibodies use unmu-
C
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Figure 2 .
￿
Heavy chain variable region sequences ofBALB/c anti-dsDNA
mAbs obtained by mRNA dideoxy sequencing compared with their ap-
propriate VH, DH, and JH genes. Overlining indicates the CDRs.
VH1
2B11 .1
igG T15 ANTI-dsDNA ANTIBODIES
GAGGTGAAGCTGGTGGAATCTGGAGGAGGCTTGGTACAGCCTGGGGGTTCTCTGAGACTCTCCTGTGCAA
___________________________________________________________________
70
VH1
2811 .1
VH11
E
_
V
_
K
_
L
_
V E S G G
_ _ _ _ _
10
G L
_ _
V Q
_ _
P G
_ _
G S
_ _
L R
_ _
20
L S C
_ _ _
C8.5
VH11 _________________G---------------------------------------------------- 702 .1312
C8 .5 ______________________________________________________________________ W .12
7D2 .G12 ______________________________________________________________________
R4A.12 __________________________________________________________________
30 40
VH1 CTTCTGGGTTCACCTTCAGTGAT~TACATGGAGTGGGTCCGCCAGCCTCCAGGGAAGAGACTGGAGTG 140 VH1 A T S G F T F S D F Y M E W V R Q P P G K R
2B11 .1 ______________________________________________________-_______________ 2811 .1 _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
VH11 __________________C_____A_______AGC____________________A___GC___T____- VH11 _ _ _ _ _ _ _ T _ Y S _ _ _ _ _ _ _ _ _ _ A
C8 .5 ______________________________________________________________________ C8.5 _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
702 .G12 ______________________________________________________________________ 702 .1312 _ _ _ _ _ _ _ _ _ _ _ _ _ - _ _ _ _ _ _ _ _
R4A .12 ______________________________________________________________________
W . 12 _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
VH1 GATTGCT TAGAAA AA CTAATGATTA A A AGAGTA A T CAT TG GA~GG CGGTTC 210
2811 .1 ______________________________________________________________________
VH1 L E W I A A S R N K A N D Y T T E Y S A S V
VH11 -T_G_G_TTT_T__________________G___C___________________________________ 2811 .1 _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _
C8 .5 _____________________________________________________________________-
7D2 .G12 ______________________________________________________________________ VH11 L G F I _ _ _ _ _ G _ _ _ _ _ _ _ _ _
R4A .12 ______________________________________________________________________ C8 .5 - - - - - - - - - - - - - - - - - - - - - -
702 .1312
W . 12
VH1 ATCGTCTCCAGAGACACTTCCCAAAGCATCCTCTACCTTCAGATGAATGCCCTGAGAGCTGAGGACACTG 280
2B11 .1 _____________________________________________________________________-
VH11 _C_A__________T-A__________________T_____A_____CA__________________G-- 70 80 82 A B C
C8 .5 ______________________________________________________________________ VH1 K G R F I V S R D T S Q S I L Y L Q M N A L
70KG12 _____________________________________________________-_______________- 2811 .1 _ _ _ _ _ _ _ _ _ _ _ _ _ - _ _ _ _ _ _ _ _
R4A .12 __________________________________________-___________-_______________
VH11 _ _ _ _ T I _ _ _ N _ _ _ _ _ _ _ _ _ _ T _
C8 .5 - - - - - - - - - - - - - - - - - - - - - -
VH1 CCATTTATTACTGTGCAAGAGAT 303 702 .1312 - - - - - - - - - - - - - - - - - - - - - -
2811 .1 W .12 - - - - - - - - - - - - - - - - - - - - - -
VH11 C-------------------
C8 .5 --------------------- C ;,
90 95 r00 -A B C--D 702 .1312
RA4.12
-----------------------
----------------------- VH1 R A E 0 T A I Y Y C A R D
2811 .1 - - - - - - - - - - - - - N T T A T V F
VH11 - - - - S - T - - - - - -
C8 .5 - - - - - - - - - - - - A Y Y Y G S S S L W
B
OJ REGIONS 7D2.G12 - - - - - - - - - - - - - I N Y G S S W Y F
R4A.12 _ _ _ _ _ _ _ _ _ _ _ _ _ R I P M
D in
N OLF16.2 N JH3 Frame
E F 110
ATTACTACGGCTAC TTTGCTTACTGGGGCCAAGGGACTGTGGTCACTGTCTCTGCAG 2811 .1 A Y W G Q G T L V T V S S
2811 .1 _A____________ GGTT ------------------------ C------------------ C8 .5 Y F D V W G A G T T V T V S S
702 .1312 D V W G A G T T V T V S S
W . 12 D Y W G Q G T S V T V S S
N DFL16.1 N JH1
TATTACTACGGTAGTAGCTAC CTGGTACTTCGATGTCTGGGGCGCAGGGACCACGGTCACCGTCTCCTCAG
C8 .5 -------------------C_ CT -___ __________________________-__ ._____
7D2.G12 ATAA _______ ___T
Table 2. Antigen Binding
Cell line dsDNA binding
cpm
2811 .1 1,950
C8.5 1,211
7D2.G12 1,069
R4A.12 1,218
S107 304
U4 1,008tated germline VH genes except C8.5, which has a GAT to
GCC substitution in VH11, thereby generating an alanine
residue instead of an aspartic acid at position 101 in the pro-
tein sequence. Because these substitutions in C8.5 occur at
the DHJH junction, it is probable that these changes arose
by addition of N sequence and not by somatic point muta-
29 1
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Figure 3.
￿
K Light chain sequences of BALB/c anti-dsDNA mAbs obtained by mRNA dideoxy sequencing.
tion . Fig . 2 b shows theDHJH regions of all four antibodies
as compared with the germline genes from which they are
derived. Only the 2B11.1 antibody has a nucleotide substitu-
tion that is unquestionably due to somatic mutation . A sub-
stitution in the JH3 region ofCTG for GTG in amino acid
number 108 as seen in Fig. 2 c causes a conservative amino
2811 VK 7D2.G12 WK
FR1
1 L0 FR1
CGC OCT GIG GAC ATT GIG ATG `ICA CAG TCT CCA TCC TCC CIA OCT GTG TCA 1 10
Arg Ala Val Asp Ile Val Met Ser Gin Ser Pro Ser Ser Leu Ala Val Ser OTT OTC AGA TOT GAC ATC CAG ATG ACT CAG TCT CCA OCT ICA CTG TCT GCA
Val Val Arg Cys Asp Ile Gin Met Thr Gin Ser Pro Ala Ser Leu Ser Ala
CORI
-
CDRI
GTT GGA
20
GAG AAG GTT ACT ATC ALC TGC AAG TCC AGT
27
CAG
27A
AGC
27B 27C
CTT TTA
27D
TAT
27E
AGT
ALL
20
ATC
30
TAC Val Gly Glu Lys Val Thr Met Ser Cys Lys Ser Ser Gin Ser Ser Leu Tyr Ser TCT
Ser
GIG
Val
GGA GAA ACT OTC
Gly Glu Thr Val Thr Ile
ALA TOT GGR GCA
Thr Cys Gly Ala
AGT
Ser
GAG
Glu
A4T
Asn
ATT
Ile Tyr
GOT
Gly
FR2
FR2
27F
AGC RAT
30
CAA AAG AAC TAC TTG GCC TOO TAC CAG CAG AAA
40
CCA GGG CAG TCT CCT 40
Ser Asn Gin Lys Asn Tyr Leu Aid Trip Tyr Gin Gin Lys Pro Gly Gln Ser Pro OCT TTA RAT TGG TAT CAG COG AAA CAG GGA AAA TCT CCT CAG CTC CTG ATC TAT
Ala Leu Asn Trp Tyr Gin Arg Lys Gin Gly Lys Ser Pro Gln Leu Leu Ile Tyr
COR2 FR3
COR2
50 60
50 FR3 60
AAA CIO CTG ATT TAC TOG GCA TCC ACT AGO GAA TCT GGG OTC CCT GAT CGC TIC GGT GCA ACC AAC TTG GCA GAT GGC ATG TU TLG AGO TTC AGT GGC AGT GGA TCT
Lys Leu Leu Ile Tyr Trp Ala Ser Thr Arg Glu Ser Gly Val Pro Asp Arg Phe
Gly Ala Thr Asn Leu Ala Asp Gly Met Ser Ser Arg Phe Ser Gly Ser Gly Ser
70 80
70 80
GOT AGA CAG TAT TCT CTC AAG ATC AGT AGC CIO CAT CCT GAC GAT GTT GCA ACG
ACA GGC AGT GGA TCT GGG ACA GAT TTC ACT CTC ACC ATC AGC AGT GIG AAG OCT
Gly Arg Gin Tyr Ser Leu Lys Ile Ser Ser Leu His Pro Asp Asp Val Ala Thr
Thr Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Val Lys Ala
COR3 J k FR4
COR3 J k FR4
TAT TAC
90
TOT CAA AAT GIG TTA AGT OCT
95G
TGG ACG TTC GOT GGA GGC ACC AAG
GAA GAC CTG GCA GTT TAT
90
TAC TGT CAG CAA TAT TAT AGC TAT
95
CCT COG ACG TIC
Tyr Tyr Cys Gin Asn Val Leu Ser Ala Pro Trp Thr Phe Gly Gly Gly Thr Lys
Glu ASP Leu Ala Val Tyr Tyr Cys Gln Gin Tyr Tyr Ser Tyr Pro Arg Thr Phe
Ck
Ck CTG GAA ATC AAA COG OCT GAT
GGA GGC ACC AAG CTG GAA ATC AAA CGG OCT GAT Leu Glu Ile Lys Arg Ala Asp
Gly Gly Thr Lys Leu Glu Ile Lys Arg Aid Asp
B R4A.12 Vk
C8 .5 Vk
FR1
FR1 1 10
1 10 TCC AGC AGT GAT GTT GIG ATG ACC CAA ACT CCA CTC TCC CTG CCT OTC AGT
OTC TCT GAT TCT AGO GCA GAA ACA ACT GIG ACC CAG TCT CCA GCA TCC CTG TCC Ser Ser Ser Asp Val Val Met Thr Gin Thr Pro Leu Ser Leu Pro Val Ser
Val Ser ASP Ser Arg Ala Glu Thr Thr Val Thr Gin Ser Pro Ala Ser Leu Ser
CDRI 20 COR1 27 27A 278 27C 210 27E
20 30 CTT GGA GAT CAA GCC TCC ATC TCT TGC AGA TCT AGT CAG AGC CTT GTA CRC AGT
ATG OCT ATA GGA GAA AAA GTC ACC ATC AGA TGC ATA ACC AGC ACT GAT ATT GAT Leu Gly Asp Gin Ala Ser Ile Ser Cys Arg Ser Ser Gin Ser Leu Val His Ser
Met Ala Ile Gly Glu Lys Vat Thr Ile Arg Cys Ile Thr Ser Thr Asp Ile Asp
FR2 FR2
40 30 40
GAT GAT ATG AAC TOO TAC CAG CAG AAG CCA GGG GAA CCT CCT AAG CTC CTT ATT MT GGA AAC ACC TAT TTA CAT TOO TAC CTG CAG AAG CCA GGC CAG TCT CCA AAG
Asp Asp Met Asn Trp Tyr Gin Gin Lys Pro Gly Glu Pro Pro Lys Leu Leu Ile Asn Gly Asn Thr Tyr Leu His Trp Tyr Leu Gln Lys Pro Gly Gin Ser Pro Lys
COR2 FR3
50 60 COR2 FR3
TCA GAA GGC RAT ACT CTT COT CCT GGA OTC CCA TCC CGA TIC TCC AGC AGT GGC 50 60
Ser Glu Gly Asn Thr Leu Arg Pro Gly Val Pro Ser Arg Phe Ser Ser Ser Gly CTC CIO ATC TAC AAA GTT TCC AAC CGA TTT TCT GGG OTC CCA GAC AGO TTC AGT
Leu Leu Ile Try Lys Val Ser Asn Arg Phe Ser Gly Val Pro Asp Arg Phe Ser
70 80
TAT GOT ACA GAT TTT GTT ITT ACA ATT GAA AAC ATG CTC TCA GAA GAT GTT GCA 70 80
Tyr Gly Thr Asp Phe Val Phe Thr Ile Glu Asn Met Leu Ser Glu Asp Val Ala GGC AGT GGA TCA GGG ACA GAT TIC ACA CTC AAG ATC AGC AGA GIG GAG GCT GAG
Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Lys Ile Ser Arg Val Glu Ala Glu
COR3 Jk
90 95 FR4
GAT TAC TAC TGT TTG CAA AGT GAT ARC TTG CCT CTC ACG TTC GOT OCT GGG ACC COR3 Jk FR4
Asp Tyr Tyr Cys Leu Gin Ser Asp Asn Leu Pro Leu Thr Phe Gly Ala Gly Thr 90 95
GAT CTG GGA GTT TAT TIC TGC TCT CAA ACT ACA CAT GTT CCT TOO ACG TIC GOT
Asp Leu Gly Cal Tyr Phe Cys Ser GIn Ser Thr His Val Pro Trp Thr Phe Gly
Ck C k
AAG CIO GAG CTG AAA COG OCT GAT GGA GGC ACC AAG CTG GAA ATC AAA LOG GCT GAT
Lys Leu Glu Leu Lys Arg Ala Asp Gly Gly Thr Lys Leu Glu Ile Lys Arg Ala Aspacid replacement of a leucine for a valine in the fourth frame-
work region . The sequence of the 5' end of the DFL16.2
region in the 21311 .1 antibody isAAT instead ofATT at amino
acid position 96 which leads to an isoleucine to asparagine
change. Thismay also represent N sequence rather than mu-
tation . In this antibody the D region is out of frame relative
to the most commonly used translation frame . In contrast,
the C8.5 and 7132.1312 DFL16.1 genes are read in the most
commonly used frame. Both the C8.5 antibody and the
7D2.G12 antibody have changes at the 3' end of their D
regions . The substitution of a TCC for TAC at amino acid
position 10013 in C8.5 causes a tyrosine to serine change, and
the AGC to AGT change at amino acid position 100A in
7D2.G12 is silent . These latter three changes are likely to
have resulted from N sequence addition because o£ their prox-
imity to the VD or DJ junctions . Finally, the R4A.12 anti-
body uses an extremely short D region that is not related
to any ofthose previously described, therefore its usual reading
frame can not be determined, nor can the degree of somatic
mutation it exhibits be determined .
The light chain genes expressed by these cell lines are all
different from each other, as shown in Fig. 3 . The 2B11.1
antibody uses a Vk gene that is a member of the Vk8 family
(Fig. 3 a) . Its sequence is completely identical to a produc-
tively rearranged but unexpressed light chain gene of the plas-
macytoma PC3609 from an NZB mouse whose antigen
binding specificity is unknown (31, 32), and it is also 98%
homologous to an antilysozyme antibody, Gloop 5 (33) . While
the 21111.1 VK gene is highly homologous to two rearranged
Vk genes, it is only 88.3% homologous to a germline Vk
gene,Vser, cloned from liverDNA (34) . Therefore, the 21311.1
Vk is probably derived from an as yet unidentified germline
gene and may itself, like the productively rearranged unex-
pressed but PC3609 Vk, constitute the unmutated sequence .
The 7132.1312 antibody uses a light chain V region that be-
longs to the Vk 12,13 family (Fig . 3 c) . It exhibits greatest
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Cold CTdsDNA (15,u/ml) was preincubated with serum-
free supernatant from hybridoma cell lines for 1 h at 37°C followed by
addition of 15,000 cpm nick-translated dsDNA and incubation for 1 h
at 37°C . Final concentration of mAb was 6.3 /Ag/ml. Serum from an
MRL/lpr mouse was diluted 1:1,000 in serum-free supernatant as theDNA
binding of this dilution of serum corresponds to the DNA binding of
mAb at 6 .3 /Ag/ml .
homology (84.2%) to a germline gene K2 cloned from the
MOPC-149 myeloma and from BALB/c embryo DNA (35) .
It is likely again that the appropriate Vk germline gene has
not yet been cloned and sequenced . The C8.5 cell line uses
a Vk gene that is a member of the Vk20 gene family (Fig.
3 b) (36) and the R4A.12 Vk gene is completely identical
to a Vk1 germline gene, K5.1, cloned from BALB/c embryo
liver DNA (Fig . 3 d) (37) .
The relative binding of these S107 VH-encoded antibodies
for dsDNA was analyzed by inhibition assays. The mono-
clonal antibody concentrations used in these assays were 0.63
Ag per well (Fig. 4) . All four antibodies were inhibited to
50% ofmaximum dsDNA binding by ds-calf thymus DNA
concentrations between 0.2 and 1.0 micrograms per well. From
these data, one can derive an apparent binding constant of
109 to 1010 for these antibodies using the equation of Nieto
et al . (38) .
The four anti-DNA antibodies were also analyzed by
ELISAs to determine their antigenic cross-reactivity . Because
the antibodies are encoded by the VH1 and VH11 gene
members of the S107 VH family, they were analyzed for
binding to PC-KLH and influenza, and no binding to either
antigen was seen . They were also analyzed for binding to
mycobacterium 65kd protein, phosphaddylethanolamine (PE),
phosphatidylinositol (PI), phosphatidylserine (PS), L-ac-
Glycerophosphorylcholine, andp-aminophosphorycholine . No
binding was seen to any of these exogenous antigens . Binding
was analyzed to the autoantigens thyroglobulin and murine
cardiac myosin and no binding was demonstrated (Table 3) .
Discussion
We have isolated four anti-dsDNA mAbs from BALB/c
mice that resemble the pathogenic type autoantibodies
Table 3.
￿
Antigen Reactivity on ELISA
Antigens
ssDNA
Thyroglobulin
Myosin
Cardiolipin
Influenza
Mycobacterium
Phosphatidylethanolamine
Phosphatidylinositol
Phosphatidylserine
L-a-Glycerophosphorylcholine
p-Aminophosphorylcholine
A Novel Class of Anti-DNA Antibodies Identified in BALB/c Mice
Reactivity on ELISA
21311 .1 C8.5 7D2,G12 R4A.12
All ELISAswere performed using antibody at aconcentration of10,ug/ml .
(+/-) Binding above the mean of irrelevant antibodies, but <2 SD above
the mean.described in autoimmune mouse strains, such as (NZB x
NZW)F1 and MRL/lpr, far more than "natural" autoanti-
bodies found in normal mouse strains. Two strategies were
used to induce the production of anti-DNA antibodies in
normal mice. One strategy was intended to induce the produc-
tion of these antibodies through somatic mutation of a re-
sponse to the bacterial antigen PC . After immunization with
PC-KLH we observed that the serological response to dsDNA
undergoes a transient rise and fail simultaneously with the
response to PC-KLH (data not shown) . This coordinate re-
sponse should occur if the antigens are potentially cross-reactive
so that certain epitopes on PC-KLH can also stimulate secre-
tion ofanti-DNA antibodies. Alternatively, as suggested by
theU4 mutant, somatic mutation ofanti-PC antibodies could
give rise to anti-DNA antibodies in a PC-immunized host .
The second strategy we used to induce anti-DNA anti-
bodies in BALB/c mice was to immunize with anti-IJa an-
tibody in an attempt to interfere with the normal pathways
for regulating animmune response (39) . In a similar system,
Gibson et al, demonstrated that autoantibodies could be in-
duced in the offspring of B10.A(3R)(H-2b) mothers and
B10.A(5R)(H-2k) fathers when the pregnant females were
immunized with paternal lymphoid cells (40) . This immu-
nization induced the production of anti-IJk antibodies in the
gestating mothers, which crossed the placenta to the offspring
and presumably led to the depletion or inactivation of sup-
pressor T cells . When the offspring were immunized with
rat red blood cells, they developed a crossreactive response
to mouse red blood cells that is not normally seen in naive
syngeneic animals. We believe that the long-term cycling (over
30 wk; data not shown) of the level ofanti-DNA antibodies
that we see in anti-I-? immunized BALB/c mice might be
due to a similar perturbation in the ability of these animals
to suppress an autoimmune response. It is not possible, how-
ever, to determine whether a given antibody arose as a result
of a particular immunization protocol. More extensive sero-
logical and molecular analysis must be undertaken in order
to ascertain the role that these immunizations might play
in eliciting these antibodies, or whether they might occur
in unimmunized animals as well.
Although anti-DNA activity is mostcommonly measured
by ELISA, this method detects low affinity crossreactive an-
tibodies as well as the high affinity, monospecific antibodies
that are seen in autoimmune disease (41) . We, therefore, chose
to measure the binding of our antibodies to dsDNA by a
liquid phase assay (millipore filter assay) . The millipore filter
assay is used as a clinical assay because it is believed to mea-
sure the high affinity anti-dsDNA antibodies that bind in
solution and titers ofanti-DNA antibody measured with this
assay correlate with disease activity. All four antibodies dis-
play high binding ofdsDNA in solution. A low concentra-
tion (0.2-1.0 jig) ofunlabeled dsDNA inhibitor causes a 50%
inhibition of binding. These antibodies bind dsDNA with
similar avidity to theIgGmAbs that have been isolated from
autoimmune strains. Most autoantibodies from nonautoim-
mune animals bind antigen only at very high antibody con-
centrations. While it is not possible to obtain an affinity con-
stant for anti-dsDNA antibodies, these antibodies display
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apparent antigen binding constants of 109 to 10 1 °, which is,
in fact, greater then the binding constants of "natural" germ-
line, gene-encoded pentameric IgM antibodies forDNA . In
addition to their high affinity, these antibodies are highly
specific for nucleic acid antigens, and unlike IgM "natural"
autoantibodies exhibit little or no crossreactivity to a panel
of autoantigens and to exogenous antigens .
We analyzed onlyIgG antibodies as we expected to study
the somatic mutations of germline genes of the S107 gene
family that can lead to anti-DNA activity. The four autoan-
tibodies described here have VH sequences that are germline-
encoded with limitedjunctional diversity . Only one antibody,
2B11.1, has a clearly identifiable somatic point mutation in
the middle of the JH3 gene in framework 4 . Three of the
four antibodies express the VH11 gene that encodes most of
the S107 VH-expressing anti-DNA antibodies identified in
autoimmune mice. Moreover, 6G6, a VH11-encoded anti-
body from aCBA/J mouse (42), was shown to have specificity
for dsDNA (43) . This antibody is IgM and has only one
nucleotide difference from the CBA/J germline VH11 gene
at the 3' end of the antibody, resulting in an aspartic acid
to alanine substitution . Therefore, it is possible that the
VH11 germline gene may predispose an antibody to bind
DNA, even in an unmutated state .
Three of the four antibodies use a member of theDFL16
family, the significance ;of which is unclear. No such predom-
inance is seen in the VDJ sequences ofanti-DNA antibodies
that have been reported from autoimmune mice or from
normal mice. However, since these antibodies describe a novel
class of autoantibodies that are high affinity for DNA de-
spite being germline gene encoded, and it has been shown
that CDR3 is important forDNA binding, it is possible that
the usage of the DFL16 family may be significant . It will
be necessary to examine more antibodies of this class to un-
derstand the importance ofspecificD region families for DNA
binding activity . However, it has been suggested that anti-
DNA antibodies often contain in their D regions positively
charged amino acids such as lysine, arginine, and histidine
or the polar but uncharged amino acids glutamine, glycine,
and asparagine which can form covalent bonds to nucleic acid
bases (15, 44, 45) . An absolute requirement ofa given number
of these residues for DNA binding to occur has not been
established, however, and the presence ofone such amino acid
in theCDR3 of each of the antibodies may be sufficient for
dsDNA binding. Also it has been proposed that theD regions
in autoantibodies are often read in an unusual frame (46) .
TwoD regions in these antibodies are unremarkable in this
respect; however, a third is read in an uncommon frame and
the fourth derives from an unidentifiedD segment . The D
region from R4A.12 antibody is very short and cannot be
assigned to any of the previously describedD regions . Ex-
tremely shortD regions havebeen found in antidextran anti-
bodies, and have also been described inanti-RNA antibodies
(15) . Because these D's are so short it is often difficult to
assign them to a family, or to distinguishD segment from
N sequence .
It is more difficult to ascertain whether somatic mutation
has occurred in the Vk genes . The R4A.12 Vk gene clearlyexpresses an unmutated sequence, while the other three anti-
bodies probably use germline genes that have not yet been
cloned and sequenced. Because there is a rearranged Vk se-
quence that is 100% identical to the 2B11.1 Vk, we believe
that the 2B11.1 Vk gene represents a germline gene sequence
that has not as yet been cloned . The sequence that is iden-
tical to the 2B11.1 Vk is an unexpressed double recombina-
tion product from an NZB plasmacytoma, PC3609 . The ex-
pressed light chain from this IgG2b secreting cell line is a
member of the Vx14 family, while the unexpressed light
chain is a member of the VK8 family. Because this rearrange-
ment is not expressed, and has not undergone selection by
antigen, the likelihood that it represents an unmutated se-
quence is increased . The C8.5 and the 7D2.G12 cell lines both
use Vk genes that are members of families whose germline
sequences have not been completely analyzed, so we cannot
know whether these hybridoma Vk sequences represent
germline sequences or not . Previous studies, however, have
shown that in general somatic mutations in the heavy and
light chain variable regions tend to accumulate concurrently.
Thus, when the heavy chain variable regions do not exhibit
mutations, the light chain variable regions are also unmutated .
We have described a set ofanti-DNA antibodies exhibiting
unusual properties that do not permit their classification ei-
ther as "natural" autoantibodies or as autoantibodies associated
with autoimmune disease. These antibodies are IgG, bind
DNA with high avidity, do not crossreact with non-nucleic
acid antigens, and are the products of unmutated Ig genes .
These binding and isotypic properties are, in general, associated
with the somatically mutated antibodies that are part of au-
toantibody responses seen in autoimmune disease ; however,
the apparent absence of somatic mutation that is seen in these
antibodies is a property characteristic of "natural" autoanti-
bodies . We are currently investigating the pathogenic poten-
tial of these antibodies in BALB/c mice.
These observations generate several questions regarding the
regulation of autoantibodies in nonautoimmune and autoim-
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individuals and autoimmune mice by somatic mutation of
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they are always the products of somatic mutation . The non-
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This might implytwo pathways of regulation ; one for less
mature B cells without somatic mutation and one for more
mature B cells that have accumulated somatic mutations. Mat-
zinger and Guerder have formulated a similar hypothesis re-
garding the differential regulation of immature and mature
T cells (47) . We hypothesize that inautoimmune disease the
defect may exist solely in the regulation of mature B cells
whose autospecificity is acquired by somatic mutation . For
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origin and regulation in both nonautoimmune and autoim-
mune mice .
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